oncology2_1900x368.jpg

New MLT-based therapeutic developments


Lipopharma currently investigates the therapeutic applications of new compounds based on our innovative Membrane Lipid Content Modification approach.

 

LP30171 is a new fatty acid derivative currently being investigated as a potential treatment for cancer and metabolic disorders.

 

© 2019 Lipopharma Therapeutics. All rights reserved | legal notice

Ctra. de Valldemossa Km. 7,4. ParcBIT. Edifici Disset. 2n. Mod. C-8. E07121 - Palma de Mallorca. Spain  | Phone/Fax: +34 971439886  |  Email: info@lipopharma.com

Login Form